Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
143,603,750
-
Share change
-
+2,351,033
-
Total reported value
-
$7,812,893,457
-
Put/Call ratio
-
147%
-
Price per share
-
$54.41
-
Number of holders
-
264
-
Value change
-
+$135,085,946
-
Number of buys
-
113
-
Number of sells
-
146
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q3 2017
As of 30 Sep 2017,
SEATTLE GENETICS INC - COM (SGEN) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
143,603,750 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and MANNING & NAPIER ADVISORS LLC.
This page lists
264
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.